The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Sigmund Silber

Showing 1-20 of 20 articles
Identification of the type of stent with three-dimensional optical coherence tomography: the SPQR study
Cortes C, Chu M, Schincariol M, Martínez-Hervás Alonso M, Reisbeck B, Zhang R, Murasato Y, Chen S, Lavarra F, Tu S, Silber S, Gutiérrez-Chico J
June 11, 2021 | 10.4244/EIJ-D-20-00598
Five-year clinical outcomes of zotarolimus-eluting stents in coronary total occlusions
Kelbæk H, Yeh R, Engstrøm T, Neumann F, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S
March 19, 2021 | 10.4244/EIJ-D-19-00866
Coronary interventions
Identification of the type of stent with three-dimensional optical coherence tomography: the SPQR study
Cortes C, Chu M, Schincariol M, Martínez-Hervás Alonso M, Reisbeck B, Zhang R, Murasato Y, Chen S, Lavarra F, Tu S, Silber S, Gutiérrez-Chico J
September 15, 2020 | 10.4244/EIJ-D-20-00598
Coronary interventions
Five-year clinical outcomes for the Resolute zotarolimus-eluting stent in total coronary occlusions
Kelbæk H, Yeh R, Engstrøm T, Neumann F, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S
November 20, 2019 | 10.4244/EIJ-D-19-00866
Coronary interventions
Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial
Fajadet J, Neumann F, Hildick-Smith D, Petronio A, Zaman A, Spence M, Wöhrle J, Elhadad S, Roberts D, Hovasse T, Valdes M, Silber S
January 20, 2017 | 10.4244/EIJV12I13A262
Coronary interventions
Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial Program
Di Mario C, Serruys P, Silber S, Lu S, Wang W, Widimsky P, Xu B, Windecker S
November 20, 2016 | 10.4244/EIJV12I10A199
Coronary interventions
Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program
Abdel-Wahab M, Neumann F, Serruys P, Silber S, Leon M, Mauri L, Yeung A, Belardi J, Widimsky P, Meredith I, Saito S, Richardt G
July 20, 2016 | 10.4244/EIJY15M07_07
Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions
Kelbæk H, Holmvang L, Richardt G, Eberli F, Stella P, Buszman P, Neumann F, Serruys P, Windecker S, Widimsky P, Belardi J, Silber S
October 20, 2015 | 10.4244/EIJY14M07_14
Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial
Chevalier B, Wijns W, Silber S, Garcia E, Serra A, Paunovic D, Serruys P
September 22, 2015 | 10.4244/EIJY14M12_13
Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention
Vranckx P, Kalesan B, Stefanini G, Farooq V, Onuma Y, Silber S, de Vries T, Jüni P, Serruys P, Windecker S
June 19, 2015 | 10.4244/EIJV11I2A31
The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment
Stella P, Belkacemi A, Waksman R, Stahnke S, Torguson R, Von Strandmann R, Agostoni P, Sangiorgi G, Silber S
October 28, 2011 | 10.4244/EIJV7I6A113
Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial
Silber S, Gutiérrez-Chico J-L, Behrens S, Witzenbichler B, Wiemer M, Hoffmann S, Slagboom T, Harald D, Suryapranata H, Nienaber C, Naber C, Chevalier B, Serruys P
May 17, 2011 | 10.4244/EIJV7I1A13
Clinical results after coronary stenting with the GenousTM Bio-engineered R stentTM: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry
Silber S, Damman P, Klomp M, Beijk M, Grisold M, Ribeiro E, Suryapranata H, Wójcik J, Sim K, Thijssen J, de Winter R
February 21, 2011
Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity
Vranckx P, Cutlip D, Mehran R, Kint P-P, Silber S, Windecker S, Serruys P
February 25, 2010
Transferability of data between different drug-eluting stents
Magro M, Onuma Y, Silber S, Serruys P
November 15, 2009 | 10.4244/EIJV5I5A85
Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007
Daemen J, Simoons M, Wijns W, Bagust A, Bos G, Bowen J, Braunwald E, Camenzind E, Chevalier B, Di Mario C, Fajadet J, Gitt A, Guagliumi G, Hillege H, James S, Jüni P, Kastrati A, Kloth S, Kristensen S, Krucoff M, Legrand V, Pfisterer M, Rothman M, Serruys P, Silber S, Steg P, Tariah I, Wallentin L, Windecker S
January 20, 2009
Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)™
Duckers H, Soullié T, den Heijer P, Rensing B, de Winter R, Rau M, Mudra H, Silber S, Benit E, Verheye S, Wijns W, Serruys P
November 20, 2007
'Fused-Gold' vs. 'Bare' stainless steel NIRflex stents of the same geometric design in diseased native coronary arteries. Long-term results from the NIR TOP Study
Fort S, Kornowski R, Silber S, Lewis B, Bilodeau L, Almagor Y, van Remortel E, Morice M, Colombo A
August 20, 2007
Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent
Duckers H, Silber S, de Winter R, den Heijer P, Rensing B, Rau M, Mudra H, Benit E, Verheye S, Wijns W, Serruys P
May 22, 2007
Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial
Chevalier B, Serruys P, Silber S, Garcia E, Suryapranata H, Hauptmann K-E, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D
February 20, 2007

Latest news

EDITORIAL
A State-of-the Art and Mini Focus on Intracoronary OCT; Thrombectomy for Acute Ischaemic Stroke; and more…
June 11, 2021
NEW
Intracoronary OCT: State of the Art and Future Directions
Ziad A. Ali et al.
June 11, 2021
PCR Companion attending EuroPCR? Activate your free subscription!
May 28, 2021
TRIALS BOOK
Access the full Trials Book 2021
(Thanks to the support of Biotronik)
May 18, 2021
JAA
This Week's JAA's: ABSORB DAPT, OFR in predicting post-PCI FFR and more...
June 8, 2021
NEW
Joint EAPCI/ACVC expert consensus on pVADs
Alaide Chieffo et al.
May 31, 2021
JAA
New JAA's: Impact of HPR on clopidogrel monotherapy and more...
May 25, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke